Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Bioquell Plc

18 May 2015 11:30

RICHARD SNELLER - Form 8.3 - Bioquell Plc

RICHARD SNELLER - Form 8.3 - Bioquell Plc

PR Newswire

London, May 18

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Richard Edgar Sneller (b) Owner or controller of interests and shortpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient. For a trust, the trustee(s),settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to Bioquell PLCwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held/dealing undertaken: 18/05/2015 For an opening position disclosure, state thelatest practicable date prior to thedisclosure (f) In addition to the company in 1(c) above, NOis the discloser making disclosures in respectof any other party to the offer? If it is a cash offer or possible cash offer,state "N/A" 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. (a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any) Class of relevant security: Interests Short positions Number % Number % (1) Relevant securities owned 1,200,000 2.8and/or controlled: (2) Cash-settled derivatives: (3) Stock-settled derivatives(including options) andagreements to purchase/sell: TOTAL: 1,200,000 2.8 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including tradedoptions), or agreements to purchase or sell relevant securities, should begiven on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors' and otheremployee options) Class of relevant security in -relation to which subscription rightexists: Details, including nature of the -rights concerned and relevantpercentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities - (b) Cash-settled derivative transactions Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position - (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. - (ii) Exercise Class of Product Exercising/ Number of Exercise price relevant description exercised securities per unit security against e.g. call option - (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion - 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: Irrevocable commitments and letters of intent should not be included. Ifthere are no such agreements, arrangements or understandings, state "none" none (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" none (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 18/05/2015 Contact name: Richard Sneller Telephone number: 01312752198 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's disclosure requirements on+44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
30th Nov 201810:59 amRNSForm 8.3 - Bioquell
30th Nov 20187:05 amRNSOffer by Ecolab U.S. 2 Inc.
12th Nov 20184:31 pmRNSHolding(s) in Company - Replacement
9th Nov 201810:22 amRNSBlock listing Interim Review
7th Nov 20183:31 pmRNSHolding(s) in Company - Replacement
7th Nov 20189:12 amRNSHolding(s) in Company
3rd Sep 20187:47 amRNSTotal Voting Rights
1st Aug 20183:38 pmRNSTotal Voting Rights
24th Jul 20187:00 amRNSHalf-year Report
2nd Jul 20183:34 pmRNSTotal Voting Rights
11th Jun 20189:26 amRNSStatement re Block Listing Application
1st Jun 201812:02 pmRNSTotal Voting Rights
25th May 20188:05 amRNSDisposal
8th May 201810:18 amRNSBlock listing Interim Review
2nd May 201811:11 amRNSStatement re Purchase of Own Shares
1st May 20188:55 amRNSStatement re Purchase of Own Shares
30th Apr 20189:36 amRNSStatement re Purchase of Own Shares
27th Apr 20188:19 amRNSStatement re Purchase of Own Shares
26th Apr 201810:58 amRNSStatement re Purchase of Own Shares
25th Apr 20182:26 pmRNSStatement re Purchase of Own Shares
24th Apr 201810:04 amRNSStatement re Purchase of Own Shares
23rd Apr 20183:49 pmRNSResult of AGM
23rd Apr 20187:00 amRNSAGM Statement
21st Mar 20187:58 amRNSAnnual Financial Report
12th Mar 20189:13 amRNSHolding(s) in Company
7th Mar 20187:00 amRNSFinal Results
9th Jan 20187:00 amRNSTrading Statement
8th Jan 20183:39 pmRNSFurther re Disposal
2nd Jan 201811:54 amRNSTotal Voting Rights
9th Nov 201712:49 pmRNSBlock listing Interim Review
2nd Oct 20177:51 amRNSTotal Voting Rights
22nd Aug 20172:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20172:08 pmRNSDisposal
26th Jul 20177:00 amRNSHalf-year Report
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 201712:48 pmRNSMiscellaneous replacement - Purchase of Own Shares
30th Jun 201712:45 pmRNSStatement Re Purchase of Own Shares
29th Jun 20178:59 amRNSStatement re Purchase of Own Shares
27th Jun 20179:19 amRNSStatement re Purchase of Own Shares
16th Jun 20178:35 amRNSStatement re Purchase of own shares
12th Jun 201710:39 amRNSStatement re Purchase of Own Shares
5th Jun 20178:28 amRNSStatement re Purchase of own shares
1st Jun 20171:07 pmRNSDirector/PDMR Shareholding
17th May 20174:31 pmRNSDirector/PDMR Shareholding
9th May 201710:24 amRNSBlock listing Interim Review
9th May 20178:51 amRNSStatement re Purchase of Own Shares
4th May 20173:00 pmRNSStatement re Block Listing Application
3rd May 201711:57 amRNSDirector/PDMR Shareholding
3rd May 20177:00 amRNSStatement re Share Buyback Programme
2nd May 201712:38 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.